
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis
Yuepei Zou, Zhonghua Sun, Shuangming Sun
The Journal of Biochemistry (2020) Vol. 168, Iss. 5, pp. 535-546
Closed Access | Times Cited: 50
Yuepei Zou, Zhonghua Sun, Shuangming Sun
The Journal of Biochemistry (2020) Vol. 168, Iss. 5, pp. 535-546
Closed Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma
X. Li, Yunhui Li, Peilong Lian, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 37
X. Li, Yunhui Li, Peilong Lian, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 37
Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway
Qingfeng Ni, Hai Zhang, Xiaoli Shi, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 4, pp. 582-595
Open Access | Times Cited: 24
Qingfeng Ni, Hai Zhang, Xiaoli Shi, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 4, pp. 582-595
Open Access | Times Cited: 24
LncRNA HCG18 promotes osteosarcoma growth by enhanced aerobic glycolysis via the miR-365a-3p/PGK1 axis
Xiaohui Pan, Jin Guo, Canjun Liu, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 37
Xiaohui Pan, Jin Guo, Canjun Liu, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 37
LINC01123 promotes immune escape by sponging miR-214-3p to regulate B7–H3 in head and neck squamous-cell carcinoma
Huan Li, Zihui Yang, Xiangming Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 29
Huan Li, Zihui Yang, Xiangming Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 29
ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p/HMGA1 axis
Tianhang Feng, Yutong Yao, Le Luo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Tianhang Feng, Yutong Yao, Le Luo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer
Yan-Fang Chen, Zheng Chen, Jian Mo, et al.
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 26
Yan-Fang Chen, Zheng Chen, Jian Mo, et al.
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 26
LncRNA HCG18 Suppresses CD8 + T Cells to Confer Resistance to Cetuximab in Colorectal Cancer Via miR-20b-5p/PD-L1 Axis
Yanjie Xu, Jiemin Zhao, Xuefeng Ni, et al.
Epigenomics (2021) Vol. 13, Iss. 16, pp. 1283-1299
Closed Access | Times Cited: 24
Yanjie Xu, Jiemin Zhao, Xuefeng Ni, et al.
Epigenomics (2021) Vol. 13, Iss. 16, pp. 1283-1299
Closed Access | Times Cited: 24
The regulatory role of LncRNA HCG18 in various cancers
Zhuoying Du, Bei Wang, Fangshun Tan, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 4, pp. 351-360
Closed Access | Times Cited: 10
Zhuoying Du, Bei Wang, Fangshun Tan, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 4, pp. 351-360
Closed Access | Times Cited: 10
HCG18 Promotes Cell Proliferation and Stemness in Cholangiocarcinoma via the miR-194-5p/KRT18/MAPK Signaling
Guodong Tian, Lu Zuo, Jie Li, et al.
Biochemical Genetics (2025)
Closed Access
Guodong Tian, Lu Zuo, Jie Li, et al.
Biochemical Genetics (2025)
Closed Access
Recent updates of centromere proteins in hepatocellular carcinoma: a review
Zhongyuan Yang, Wenjiao Chen, Yunhui Liu, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
Zhongyuan Yang, Wenjiao Chen, Yunhui Liu, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
Upregulation of long noncoding RNAs LINC00941 and ABHD11-AS1 is associated with intrahepatic cholangiocarcinoma
Olga Y. Burenina, Н. Л. Лазаревич, I. F. Kustova, et al.
Science Progress (2025) Vol. 108, Iss. 1
Open Access
Olga Y. Burenina, Н. Л. Лазаревич, I. F. Kustova, et al.
Science Progress (2025) Vol. 108, Iss. 1
Open Access
The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
Ioana Rusu, Radu Pîrlog, Paul Chiroi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12370-12370
Open Access | Times Cited: 16
Ioana Rusu, Radu Pîrlog, Paul Chiroi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12370-12370
Open Access | Times Cited: 16
LncRNA HCG18 promotes prostate cancer progression by regulating miR-512-3p/HK-2 axis
Yaru Zhu, Zhijing Wang, Haopeng Li, et al.
Asian journal of urology (2024) Vol. 11, Iss. 4, pp. 575-585
Open Access | Times Cited: 3
Yaru Zhu, Zhijing Wang, Haopeng Li, et al.
Asian journal of urology (2024) Vol. 11, Iss. 4, pp. 575-585
Open Access | Times Cited: 3
Ferroptosis: insight into the treatment of hepatocellular carcinoma
Chuanjie Liao, Youwu He, Xingju Luo, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Chuanjie Liao, Youwu He, Xingju Luo, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Upregulated lncRNA HCG18 in Patients with Non-Alcoholic Fatty Liver Disease and Its Regulatory Effect on Insulin Resistance
Yu Xia, Yanxia Zhang, Huiyun Wang
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 4747-4756
Open Access | Times Cited: 20
Yu Xia, Yanxia Zhang, Huiyun Wang
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 4747-4756
Open Access | Times Cited: 20
AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma
Cheng Gao, Liang Chang, Tianxin Xu, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 3, pp. 1412-1433
Open Access | Times Cited: 8
Cheng Gao, Liang Chang, Tianxin Xu, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 3, pp. 1412-1433
Open Access | Times Cited: 8
Long Noncoding RNA HCG18 Promotes Malignant Phenotypes of Breast Cancer Cells via the HCG18/miR-103a-3p/UBE2O/mTORC1/HIF-1α–Positive Feedback Loop
Xu Liu, Kun Qiao, Kaiyuan Zhu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 18
Xu Liu, Kun Qiao, Kaiyuan Zhu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 18
Circular RNA circCPA4 promotes tumorigenesis by regulating miR‐214‐3p/TGIF2 in lung cancer
Wenhu Tao, Cheng Cao, Gaofei Ren, et al.
Thoracic Cancer (2021) Vol. 12, Iss. 24, pp. 3356-3369
Open Access | Times Cited: 17
Wenhu Tao, Cheng Cao, Gaofei Ren, et al.
Thoracic Cancer (2021) Vol. 12, Iss. 24, pp. 3356-3369
Open Access | Times Cited: 17
LncRNA HCG18 affects diabetic cardiomyopathy and its association with miR-9-5p/IGF2R axis
Yuhui Luo, Yi Jiang, Tingting Zhong, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24604-e24604
Open Access | Times Cited: 2
Yuhui Luo, Yi Jiang, Tingting Zhong, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24604-e24604
Open Access | Times Cited: 2
Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses
Shuang Li, Xu Wang, Tianfeng Wang, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 16
Shuang Li, Xu Wang, Tianfeng Wang, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 16
Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma
Mohamed H. Yousef, Hassan A. N. El‐Fawal, Anwar Abdelnaser
BioMed Research International (2020) Vol. 2020, pp. 1-30
Open Access | Times Cited: 15
Mohamed H. Yousef, Hassan A. N. El‐Fawal, Anwar Abdelnaser
BioMed Research International (2020) Vol. 2020, pp. 1-30
Open Access | Times Cited: 15
The Prognostic Significance and Potential Mechanism of Prolyl 3-Hydroxylase 1 in Hepatocellular Carcinoma
Chunlei Li, Lilong Zhang, Yao Xu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 9
Chunlei Li, Lilong Zhang, Yao Xu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 9
ATF2-Induced Overexpression of lncRNA LINC00882, as a Novel Therapeutic Target, Accelerates Hepatocellular Carcinoma Progression via Sponging miR-214-3p to Upregulate CENPM
Hua Ren, Zhicheng Wei, Yanxia Sun, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 10
Hua Ren, Zhicheng Wei, Yanxia Sun, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 10
TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC-induced murine hepatocarcinogenesis via centromere protein M
Yi Zhou, Shu Zhang, Guoteng Qiu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 22
Open Access | Times Cited: 1
Yi Zhou, Shu Zhang, Guoteng Qiu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 22
Open Access | Times Cited: 1
Regulatory Non-coding RNAs for Death Associated Protein Kinase Family
Qingshui Wang, You‐Yu Lin, Wenting Zhong, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 9
Qingshui Wang, You‐Yu Lin, Wenting Zhong, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 9